📰Out today!!📰

In the first wave, anticancer therapy for urological cancers did not result in an apparent excess in symptomatic #COVID19 infections at Weston Park Cancer Centre

nature.com/articles/s4141… British Journal of Cancer Cancer Research UK Syed A Hussain

Signs, symptoms and treatment of bladder cancer – your questions answered by experts
⁦Syed A Hussain⁩
⁦Fight Bladder Cancer⁩ #bladder #cancer ⁦The Telegraph⁩ telegraph.co.uk/health-fitness…

With Syed A Hussain jim catto Alex Halme & many colleagues, we're starting a DOAC #thromboprophylaxis trial in muscle-invasive #BladderCancer patients with neoadjuvant chemo. If interested in #ACBtrial , message me/comment below! #EBM PS Yes, was great to meet at #EAU24 European Association of Urology (EAU)

It was a pleasure to catch up with friends in Paris during EAU24 ⁦Nick James⁩ ⁦Kari Tikkinen⁩ ⁦💙alison birtle⁩ ⁦Andrea Necchi⁩ ⁦Yüksel Ürün⁩ ⁦jim catto⁩ RickBryan Alex Halme

Interesting work indeed. Ongoing randomised trial IMvigor 011 will no doubt shed more light on this area of research. Looking forward to completing recruitment in this important study. Yüksel Ürün

#BCaMeeting24 Kicks off with a great talk from Dr Vernonica Nanton quoting Lasagna's law: 'The number of eligible patients for a trial drops by 90% when the trial opens ... but recovers when it closes'. That explains it Peter Sasieni Syed A Hussain Tom Powles

It was pleasure to attend and present at the BEST OF ASCO GU 2024 meeting organised last Friday. Very well organised meeeting with excellent debates and excellent Q & A with audience. ⁦jim catto⁩ ⁦The University of Sheffield⁩ ⁦Sheffield Hospitals⁩ ⁦Sheffield Early Phase Cancer Trials Group⁩

🚨Its out! Does #hypoxiagene signature predict outcome to #CRT in #MIBC ?🚨Robert Huddart💙
Nuria Porta Prof Emma Hall Nick James Nuradh Joseph YeePei Song 🕷💙 Syed A Hussain Hitesh Mistry #WhereisHoskin Manchester Cancer Research Centre Division of Cancer Sciences Science and Innovation at Cancer Research UK UK Research and Innovation eBioMedicine – The Lancet Discovery Science
sciencedirect.com/science/articl…

Ready yo go live for the AZ webinar on surrogate end points and real world data on prostate cancer with Noel Clarke and Matt Sydes jim catto The University of Sheffield Sheffield Early Phase Cancer Trials Group

Ready yo go live for the AZ webinar on surrogate end points and real world data on prostate cancer with Noel Clarke and ⁦Matt Sydes⁩ ⁦jim catto⁩ ⁦The University of Sheffield⁩ ⁦Sheffield Early Phase Cancer Trials Group⁩

Thrilled to be working on the eIMMUNE study with Prof Janet Brown and Syed A Hussain

Great news on world cancer day. Delighted to be leading project with Prof Janet Brown on digital documentation of IO toxicity empowering pts. These samples with data will help 2understand & identify biomarkers of toxicity. Thankyou!. The University of Sheffield Faculty of Health | University of Sheffield Yorkshire Cancer Research

It’s #WorldCancerDay . DYK people are more likely to have their lives cut short by cancer in Yorkshire than almost anywhere else in England? But the region's research has been boosted by £8.9 million in new funding for Yorkshire Cancer Research & The University of Sheffield👇🏿

sheffield.ac.uk/news/future-ca…

📢💊🔬People are more likely to have their lives cut short by cancer in Yorkshire than almost anywhere else in England. But research in the region has received a boost with £8.9 million in new funding for Yorkshire Cancer Research & The University of Sheffield. Read more 👇🏿

sheffield.ac.uk/news/future-ca…

Absolutely delighted that we can now announce funding from this award for the Sheffield ex vivo group. Thanks to my co-lead Greg Wells and the huge collaborative team that is involved, including patients. More news to follow when we open

It was a pleasure to meet colleagues and collaborators from across the world at ASCO GU. Great conference. Exciting data and great exchange of ideas with wonderful friends, and colleagues. ⁦⁦The University of Sheffield⁩ ⁦Sheffield Early Phase Cancer Trials Group⁩ #ASCOGU24 ⁦ASCO⁩ ⁦ESMO - Eur. Oncology⁩

Thanks Yuksel Yüksel Ürün #ASCO #ASCO GU24 Faculty of Health | University of Sheffield The University of Sheffield Sheffield Hospitals Sheffield Early Phase Cancer Trials Group

Delving into the critical intersection of oncology and renal health at the ASCO Genitourinary Cancers Symposium. Intriguing data on immune checkpoint blockade therapy in metastatic bladder cancer patients with renal impairment offers valuable insights!
Thanks to Deniz for leading…